Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Arizona

UPDATED

Xenoscience
Phoenix Arizona 85004

Clinical trial for Engage + Emerge

Xenoscience
Phoenix Arizona 85004

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Center for NEUROSCIENCES
Tucson Arizona 85718

Clinical trial for Engage + Emerge

Territory Neurology & Research Institute
Tucson Arizona 85704

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

View More ▼

Phoenix Arizona 85006

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Phoenix Arizona 85006

A clinical trial to evaluate treatments using CAD106 Immunotherapy, Placebo to CAD106, CNP520 and Placebo to CNP520 for patients with Alzheimer's Disease

Phoenix Arizona 85013

A clinical trial to evaluate treatments using RVT-101 35 mg and Placebo for patients with Alzheimer's Disease, Dementia With Lewy Bodies or Parkinson's Disease Dementia

Phoenix Arizona 85006

A Phase 2 clinical study for patients with Moderate Alzheimer's Disease

Phoenix Arizona 85013

A Phase 2 clinical study for patients with Moderate Alzheimer's Disease

UPDATED

Phoenix Arizona 85006

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Phoenix Arizona 85013

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Phoenix Arizona 85004

A Phase 3 clinical study for patients with Alzheimer's Disease

Phoenix Arizona 85013

A Phase 3 clinical study for patients with Alzheimer's Disease

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of 18F-AV-1451 to evaluate Alzheimer's Disease

UPDATED

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

UPDATED

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

UPDATED

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease, Early

Phoenix Arizona 85004

Patients are needed to participate in a clinical research study of Crenezumab and Placebo to evaluate Alzheimer's Disease, Mild Alzheimer's Disease (AD)

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of Crenezumab and Placebo to evaluate Alzheimer's Disease, Mild Alzheimer's Disease (AD)

Phoenix Arizona 85020

Patients are needed to participate in a clinical research study of Crenezumab and Placebo to evaluate Alzheimer's Disease, Mild Alzheimer's Disease (AD)

Scottsdale Arizona 85259

A clinical trial to evaluate treatments using CAD106 Immunotherapy, Placebo to CAD106, CNP520 and Placebo to CNP520 for patients with Alzheimer's Disease

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Alzheimer's Disease

Scottsdale Arizona 85260

A Phase 3 clinical study for patients with Alzheimer's Disease

Sun City Arizona 85351

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Sun City Arizona 85351

A clinical trial to evaluate treatments using CAD106 Immunotherapy, Placebo to CAD106, CNP520 and Placebo to CNP520 for patients with Alzheimer's Disease

Sun City Arizona 85351

A Phase 2 clinical study for patients with Moderate Alzheimer's Disease

UPDATED

Sun City Arizona 85351

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Sun City Arizona 85351

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Sun City Arizona 85351

Patients are needed to participate in a clinical research study of Crenezumab and Placebo to evaluate Alzheimer's Disease, Mild Alzheimer's Disease (AD)

Tucson Arizona 85704

A Phase 2 clinical study for patients with Moderate Alzheimer's Disease

UPDATED

Tucson Arizona 85704

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Tucson Arizona 85718

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Tucson Arizona 85718

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease, Early

Arkansas

Fayetteville Arkansas 72703

A clinical research study of Suvorexant 10 mg, Suvorexant 20 mg and Placebo for the treatment of Insomnia or Alzheimer's Disease

Jonesboro Arkansas 72401

A Phase 3 clinical study for patients with Alzheimer's Disease

Little Rock Arkansas 72211

A clinical research study of Suvorexant 10 mg, Suvorexant 20 mg and Placebo for the treatment of Insomnia or Alzheimer's Disease

Little Rock Arkansas 72205

A Phase 3 clinical study for patients with Alzheimer's Disease

Springdale Arkansas 72764

A Phase 3 clinical study for patients with Alzheimer's Disease

California

Research Center
Additional Locations California

Clinical Research for Patient with Mild Cognitive Impairment due to Alzheimer's Disease or Mild to Moderate Alzheimer’s Disease disease

Pharmacology Research Institute, Encino
Encino California 91316

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

Sun Valley Research Center
Imperial California 92251

Adult patients suffering from Alzheimer's Disease.